we evaluated the effects of intravenous ( iv ) vasopressin on central hemodynamics , as well as myocardial and gastrointestinal ( gi ) blood flow , to delineate an optimal dosage balanced to yield maximum reduction of gi blood flow with minimal adverse cardiac effects .
C0027061
myocardial
C0018787
cardiac